Genome Integrity Analysis
Characterize genetic medicines by quantifying encapsidated genomes and identifying contaminants in viral vectors.
Overview
Form Bio's Genome Integrity Analysis is a specialized computational solution designed for developers of genetic medicines, including gene therapy and viral vector-based therapeutics. The platform characterizes genetic medicines by quantifying what is encapsidated within viral vectors, providing critical quality and safety insights throughout the development and manufacturing process.
By leveraging advanced computational methods, Form Bio enables research and development teams to gain a deeper understanding of vector composition, supporting informed decisions around vector design, safety assessment, and manufacturability optimization.
Core Capabilities
- Differentiation of full-length, functional genomes from partial or truncated genomes within viral vector preparations
- Identification and characterization of contaminants, including host cell DNA fragments and plasmid DNA fragments
- Quantification of encapsidated genetic content to provide a comprehensive picture of vector composition
- Advanced computational insights to guide vector design for improved safety, efficacy, and manufacturability
Who It Is For
- Scientists and engineers developing gene therapies and genetic medicines
- Teams requiring rigorous characterization of viral vector preparations
- Organizations seeking to optimize vector design and manufacturing processes through data-driven analysis
Form Bio's Genome Integrity Analysis simplifies a complex analytical challenge by combining bioinformatics expertise with purpose-built workflows, helping genetic medicine developers accelerate programs while maintaining a strong focus on product safety and quality.
